05/30
Headlines

CNCE

Watch List: American Diversified Holdings (OTCMKTS:ADHC), Oncomed Pharmaceuticals (NASDAQ:OMED), Concert Pharmaceuticals (NASDAQ:CNCE), Actinium Pharmaceuticals (NYSEMKT:ATNM)

Richard Atkins02 mins

American Diversified Holdings Corp (OTCMKTS:ADHC) stock performance was -16.67% in last session and finished the day at $0.0375. Traded volume was 506,482.00million shares in the last session. The beta of the stock remained 3.20. OncoMed Pharmaceuticals Inc said it halted patient enrollment and dosing in all ongoing early-stage trials of two of its experimental cancer…

Read More

Biotech Bullish Stocks: Applied Genetic Technologies (NASDAQ:AGTC), Alder Biopharmaceuticals (NASDAQ:ALDR), Concert Pharmaceuticals (NASDAQ:CNCE), Recro Pharma Inc (NASDAQ:REPH), Relypsa (NASDAQ:RLYP)

Kristen Barton03 mins

BMO Capital Markets boosted their price target on shares of Applied Genetic Technologies Corp (NASDAQ:AGTC) from $21.00 to $34.00 in a research note issued on Monday. The firm currently has an “outperform” rating on the stock. BMO Capital Markets’ target price points to a potential upside of 34.44% from the stock’s previous close. Applied Genetic…

Read More
Gilead Sciences GILD NASDAQ:GILD

Biotech Volatile Stocks: DARA Biosciences Inc (NASDAQ:DARA), Concert Pharmaceuticals Inc (NASDAQ:CNCE), Prosensa Holding NV (NASDAQ:RNA), CytRx Corporation (NASDAQ:CYTR)

Kevin Long02 mins

DARA Biosciences Inc (NASDAQ:DARA) on May 15 announced its support for Neuropathy Awareness Week which is being observed during the week of May 12, 2014 and sponsored in the U.S. by The Neuropathy Association (www.neuropathy.org). DARA Biosciences Inc (NASDAQ:DARA) stock performance was -26.61% in last session and finished the day at $1.60. Traded volume was…

Read More

Biotech Losers: PTC Therapeutics (NASDAQ:PTCT), Prosensa Holding (NASDAQ:RNA), Concert Pharmaceuticals Inc (NASDAQ:CNCE), Tetralogic Pharmaceuticals Corp (NASDAQ:TLOG), Agios Pharmaceuticals Inc (NASDAQ:AGIO)

Richard Atkins03 mins

One solution, developed by PTC Therapeutics Inc. (NASDAQ:PTCT), a US biotechnology company, is to intervene in the transcription process in which the DNA is converted first to messenger RNA and then into protein. PTC Therapeutics Inc. (NASDAQ:PTCT)’s experimental drug ataluren is designed to override the false stop signal by interacting with the ribosome – the…

Read More

Healthcare Losers: Cara Therapeutics (NASDAQ:CARA), ERBA Diagnostics Inc (NYSEMKT:ERB), Actinium Pharmaceuticals Inc (NYSEMKT:ATNM), Concert Pharmaceuticals (NASDAQ:CNCE)

Richard Atkins02 mins

Cara Therapeutics Inc (NASDAQ:CARA) — which has a preclinical cannabis compound — jumped 11.58%. The company is clearly running (smoke) rings around the competition and has the most appropriately named spokeswoman on Earth should it wish to employ the English supermodel as a mouthpiece. Cara Therapeutics Inc (NASDAQ:CARA) stock performance was -7.49% in last session…

Read More

Active Watch List: The Walt Disney Company (NYSE:DIS), Pfizer Inc. (NYSE:PFE), JinkoSolar Holding Co., Ltd. (NYSE:JKS), Concert Pharmaceuticals (NASDAQ:CNCE), ITT Corporation (NYSE:ITT)

Mark DeFrance03 mins

The Walt Disney Company (NYSE:DIS) in South East Asia (SEA) on 10 October announced changes to its management team to position for rapid growth in the film and media distribution landscape in the region. Amit Malhotra, previously General Manager Disney Media Distribution and Media+ becomes General Manager, Studio Entertainment SEA and will oversee all the…

Read More